Today’s AI Top Pick: TMDX

7/7/2026 · Highly Shorted High Growth Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted High Growth Deep RotationTMDXBUY NOW8.7 / 107/7/2026

TransMedics (TMDX) offers the cleanest multi-timeframe alignment in the pool combined with genuinely elite fundamentals and a fresh positive catalyst. On the tape, every horizon points up on mid/long: 1h fc_mid +5.7% / fc_long +82.42%, 4h fc_mid +65.75% / fc_long +124.16%, 1d fc_short +41.16% / fc_mid +66% / fc_long +55.3%, and even the 1wk is +28.57% / +26.5% on mid/long. Near_term_bullish reads 1.0 and bullish_prob is 1.0 — that is full multi-timeframe agreement, which none of the other high-score names deliver cleanly (PSIX has a savage 1wk fc_long of -62.7%; CRK has Goldman on Sell and only mixed forecasts; UWMC is near-term red on 1h/4h). Entry timing is favorable, not chasing. Price sits at $71.23 with pos_in_21bar_range at 38.88% on the daily and 9.79% on the weekly — mid-lower range, not extended. Drawdowns of -9.6% (1d) and -50.96% (1wk) from 21-bar highs show this is a deeply rotated growth name, exactly what the lens is designed to catch. Fundamentals are best-in-class for the setup: PE 16.35, ROE 45.22%, profitMargin 27.04%, operMargin 14.85%, salesYoY +30.24%, epsNextY +70.83%, and analyst recom 1.64 with +63.2% targetUpsidePct. That combination — profitable, growing >30% top-line, reasonable multiple, deep drawdown — is rare. News reinforces rather than undercuts: Stocktwits [2026-07-01] flagged an analyst 77% upside call, and Motley Fool ran two constructive pieces on 7/2 and 7/3 ("3 Growth Stocks to Buy on the Dip"). No dilution, no regulatory overhang, no short-seller report. Compare that to CRK (two Goldman/MS price-target cuts in the past week), CRWV (Cramer reversal, SeekingAlpha downgrade), or HUMA (V012 data mixed). Why today, not wait: the daily fc_short of +41.16% and 4h fc_short being flat-positive suggest the near-term inflection is already in progress with the 21-bar range still showing room. Waiting for a deeper pullback risks missing the bounce given bullish_prob 1.0 across all four TFs. The stop below the 4h low gives an asymmetric setup with 50%+ mid-term upside vs. ~10% risk.

Entry zone

$69.50 - $71.50 (buy today at market or on any dip toward the 4h dd_low ~$65.10)

Stop loss

$63.75 (below the 1d dd_from_21bar_high of -9.6% and the recent 4h base — invalidates the reversal thesis)

First target

$92.00 (aligns with 1d fc_short +41.16% / fc_mid +66% zone and prior consolidation)

Longer target

$118 - $130 (weekly fc_mid +28.57%, 4h fc_long +124.16%, and analyst target +63.2% ≈ $116)

Risks

Short float 23.02% — can cut both ways; if the reversal fails, forced short-covering support disappears and the tape retests -50% weekly drawdown zone
Debt/Equity 1.75 and healthcare-device single-product concentration (OCS platform) — any pipeline/reimbursement setback hits hard
1wk fc_short is -4.98% — the very-near-term weekly bar is still soft; a broader market pullback could delay the inflection
instOwn reported at 108.18% suggests heavy short-borrow crowding; a squeeze is possible but so is a sharp reversal if narrative breaks
PE 16.35 looks cheap but fwdPe 21.69 shows the market expects margin compression — an earnings miss would recalibrate the multiple lower

Honorable mentions

UWMCExplosive forecast stack (4h fc_mid +99%, 1wk fc_mid +130%, 1d fc_short +37.1%), near_term_bullish 1.0, deep -49.77% YTD drawdown, KBW upgrade, and 103.2% analyst upside — but debtEq 70.65 and 1.97% profit margin cap the fundamental quality vs TMDX.

PSIXTop score (15.0), position 0% in range across 1h/4h (bottom of channel), 1d fc_short +79.9%, PE 8.28, ROE 75.67%, and targetUpsidePct 91.8% — held back to #3 because the 1wk fc_long is -62.72%, a major divergence that raises risk of a bull-trap bounce.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.7	Full multi-TF alignment, best-in-class profitability (ROE 45%, PM 27%), mid-range entry, and positive analyst catalyst.
2	UWMC	BUY NOW	8.2	Massive mid/long forecasts (+99%/+130%), deep drawdown -49% YTD, and KBW upgrade — near-term 1h dip is the entry.
3	PSIX	BUY PULLBACK	7.9	Screamingly cheap (PE 8.3, PEG-adjusted growth) at range bottom, but 1wk fc_long -62.7% divergence demands patience.
4	SMCI	BUY NOW	7.6	All four TFs positive with pos_in_range 0% (1h/4h/1d) — classic oversold reversal with fund_score 6.75 and AI-cooling tailwind.
5	CRK	BUY PULLBACK	7.2	Top screen score and fund_score 7.75 (PE 6.7, PM 31%), but Goldman Sell reiteration and PT cut is a fresh headwind.
6	BYRN	BUY PULLBACK	6.9	1d/4h forecasts +77%/+119% and near_term_bullish 0.8, but pos_in_range 100% on 1d = extended into Q2 print.
7	UPST	BUY NOW	6.7	1wk fc_long +145%, all TFs positive on mid/long, SeekingAlpha Buy — short float 32.75% creates squeeze fuel.
8	KVYO	BUY PULLBACK	6.5	1wk fc_mid +104%, near_term_bullish 0.6, AI Marketing Agent catalyst — but pos_in_range 100% across 1h/4h/1d = wait.
9	CELH	BUY PULLBACK	6.3	1wk fc_mid +41%, but pos_in_range 100% on 1d and 1h fc_mid -13% signal near-term exhaustion.
10	REAX	BUY PULLBACK	6.1	1d fc_short +34% / 1wk fc_long +90%, but pos_in_range 100% across 1h/4h/1d — chasing risk.
11	VSTM	BUY PULLBACK	6.0	Near_term_bullish 1.0, 1wk fc_long +111%, RBC constructive on KRAS data — but profitMargin -391% keeps it speculative.
12	PROP	WAIT	5.7	1wk fc_long +284% and salesYoY 1350%, but 1wk fc_short -100% and debtEq 1222 = extreme binary.
13	MNDY	BUY PULLBACK	5.6	1d fc_mid +82% and Q1 beat with buyback, but pos_in_range 100% on 1h/4h — let it breathe.
14	PDYN	WAIT	5.4	Near_term_bullish 1.0 and defense contract wins, but ps 38.16 and profitMargin -358% cap conviction.
15	PCT	WAIT	5.1	salesYoY 590% and Wall Street still bullish, but ps 140 and operMargin -1563% make it a lottery ticket.
16	BRZE	BUY PULLBACK	5.0	JPM/Goldman constructive, 1wk fc_mid +30%, but near_term_bullish only 0.2 and pos_in_range 100%.
17	PGY	WAIT	4.9	Fund_score 8.0 (best in pool) but bullish_prob dropped to 0.2 and 1h/4h/1d forecasts turned red — trend is deteriorating.
18	FOUR	WAIT	4.7	1d fc_short +26% but 1h fc_long -10% and RSI 70 — extended and near-term bearish 0.2.
19	DUOL	WAIT	4.5	1d fc_long +65% but targetUpsidePct -18.6% (already above analyst targets) and DA Davidson flagged DAU stall.
20	CRWV	AVOID	4.2	Down 20% since Cramer call, SeekingAlpha downgrade on hyperscaler competition, fund_score -0.25.
21	VIA	WAIT	4.0	1d fc_long +63% but 1h/4h/1d fc_mid all red and Waymo/Uber Phoenix partnership ended — narrative wobble.
22	NRDS	WAIT	3.9	Fund_score 7.5 but SeekingAlpha downgrade on 'worsening economics' and forecasts weakening across TFs.
23	HUMA	AVOID	3.7	1wk fc_long +640% is a wild outlier; V012 data split, stock sinking on market gains, profitMargin -4840%.
24	MARA	WAIT	3.5	1wk fc_mid +29% but bullish_prob 0.2, 4h fc_long -32%, no clean catalyst.
25	BIRK	AVOID	3.2	Bullish_prob 0 and near_term_bullish 0 — all 1d forecasts negative despite Raymond James Outperform.
26	BKV	AVOID	3.0	Bullish_prob 0, 1d forecasts negative, and SeekingAlpha flags dilution — screen pass but tape rejects.
27	DLO	AVOID	2.6	RSI 77 with 1h/4h/1d fc_mid all negative (-9% to -21%) — classic parabolic exhaustion after UBS upgrade pop.
28	MUX	AVOID	2.4	Bullish_prob 0, 1d/1wk fc_long -31%/-55%, expected_return -5.2% — momentum broken.
29	ABAT	AVOID	2.2	DOE grant reinstated is old news; bullish_prob 0 and no near-term forecast confirmation.
30	TOYO	AVOID	1.8	4h/1d recent -43%/-58% collapses, $50M dilutive offering — falling knife despite cheap multiple.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord